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Rodent visual systemIn the age-related, blinding disease glaucoma, retinal ganglion cells (RGCs) degenerate, possibly affecting
glutamatergic retinofugal transmission to the brain. The superior colliculus (SC) is a major central target of
retinofugal axons in the rodent, a much used disease model. We investigated the contribution of NMDA-type
glutamate receptors to retinocollicular transmission in a rat glaucoma model, using a SC brain slice
preparation to determine the sensitivity of synaptic responses to the NMDAR antagonist D-AP5. At 32 weeks
after induction of experimental glaucoma, but not earlier, there was an increase in NMDAR contribution to SC
synaptic responses in slices receiving input from glaucomatous eyes. This suggests that there are changes in
NMDAR function after RGC degeneration in experimental glaucoma, which may represent functional SC
compensation through plasticity via NMDARs. This has implications for studies carried out using rodent
glaucoma models, especially those evaluating potential treatment strategies, as it suggests that functional
changes in the central visual system need to be considered in addition to those in the eye. Furthermore, the
data underline the need for early therapeutic intervention in order to pre-empt subsequent central
functional changes.irect.com).
icense. © 2010 Elsevier Inc. Open access under CC BY license. Introduction
Glaucoma is one of the leading causes of blindness worldwide
(Resnikoff et al., 2004). The disease leads to the apoptosis and
degeneration of the neurones that transfer visual information to the
central visual areas, the retinal ganglion cells (RGCs). Previous studies
in glaucomatous patients (Kiyosawa et al., 1989; Miki et al., 1996;
Sugiyama et al., 2006; Duncan et al., 2007a,b) and in experimental
glaucomamodels in primates (Imamura et al., 2009) have shown that
the central visual areas also show functional changes at the cortical
and sub-cortical level (Smith et al., 1993). Furthermore, anatomical
changes have also been seen in the lateral geniculate nucleus, where
RGC axons terminate, in a primate model of glaucoma (Yucel et al.,
2006). Thus, there is increasing evidence that glaucoma is a condition
that has consequences for visual areas in the brain.
Many studies looking at disease mechanisms and potential
treatment strategies for glaucoma are initially carried out using
rodent models, and there is extensive information available on the
progression of retinal degeneration in rodent glaucoma (Morrison,
2005; Pang and Clark, 2007). By contrast, relatively little is known
concerning changes in central target areas of retinal axons in rodent
glaucoma models. In rodents, the major central visual system contact
for RGCs is the superior colliculus (SC) however there are few studieslooking at the function of this area in a rat model of glaucoma. The
study by King et al. (2006) found, using extracellular multiunit
recordings that there was an expansion of the visual receptive ﬁelds of
cells in the superior colliculus in a rat glaucoma model with elevated
intraocular pressure. This result was suggested to indicate a possibility
for plasticity and compensation in the retina and superior colliculus
after RGC degeneration in this model. However these mechanisms to
date have not been investigated. Furthermore, using an approachwith
visual stimulationmakes it difﬁcult to distinguish between effects that
are due directly to retinal dysfunction and those effects that are
genuinely central.
Glutamate is the major excitatory neurotransmitter in the visual
pathway from the RGCs to the superior colliculus with NMDA
receptors being found postsynaptically (Mize and Butler, 1996; Jeon
et al., 1997). NMDA receptors have been shown to be important for
the development and reﬁnement of the correct topographic projec-
tions from RGCs to the superior colliculus (Simon et al., 1992; Shi et
al., 1997). Previous studies from our laboratory have also shown the
importance for NMDA receptors in visual function of the rat superior
colliculus during development and in adulthood (Roberts et al., 1991;
Binns and Salt, 1994, 1998). In addition to the glutamatergic
excitatory processes, there are substantial inhibitory inﬂuences
within the superior colliculus with all three types of GABA receptor
(GABAA, GABAB, and GABAC) being seen in the area from birth
(Bowery et al., 1987; Chu et al., 1990; Boue-Grabot et al., 1998;
Wegelius et al., 1998; Pasternack et al., 1999; Clark et al., 2001).
Around 45% of the cell population within the visual layers of the
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(Mize, 1988). All three groups of GABA receptor have been shown to
play a role in visual processing in the superior colliculus (Arakawa and
Okada, 1988; Hirai et al., 1993; Binns and Salt, 1997; Boller and
Schmidt, 2001, 2003; Schmidt et al., 2001) with indications of their
role in processes such as response habituation (Binns and Salt, 1997;
Platt and Withington, 1997) long term depression (Mize and Salt,
2004) and long term potentiation (Platt andWithington, 1998; White
and Platt, 2000, 2001).
As both NMDA and GABA receptors have been shown to have an
important role in visual processing in the superior colliculus it is likely
that changes that may occur to these receptors due to degeneration of
the RGC input may affect the ability of the area to function correctly.
Thus we have investigated the changes that may occur in the
contribution of these receptors to synaptic transmission in the
superior colliculus in a rat ocular hypertension (OHT) model of
glaucoma. We chose an in vitro slice preparation of the superior
colliculus so as to eliminate the complications that are involved when
using in vivo techniques with visual stimulation. In our preparation,
optic tract stimulation elicits a ﬁeld post-synaptic potential (fPSP) in
the superﬁcial grey layer of the superior colliculus that has NMDA
receptor and GABA receptor contributions that can be revealed by
application of NMDA receptor and GABA receptor antagonists. Using
such an approach, we investigated the timeline of any changes in the
contribution of these receptors to the fPSP in the superior colliculus at
3, 16 and 32 weeks after OHT induction, and we found that there was
an increase in NMDA receptor contribution to synaptic responses at
the ﬁnal time point.
Methods
All conditions and experimental procedures were carried out in
accordance with the UK Animals (Scientiﬁc Procedures) Act 1986 and
associated guidelines. Animals were obtained from Harlan UK and
given at least 48 hours to accommodate before any procedures were
performed. 44male Dark Agouti rats age 7–8 weeks (150–200 g)were
housed in a 12 hour light/12 hour dark cycle with unlimited access to
food and water. 18 of the animals had the ocular hypertension (OHT)
model induction performed with the other 26 being used as age
matched unoperated controls.
For induction of the OHT model of glaucoma, animals were
anesthetised using an intraperitoneal injection of a ketamine
(100 mg/ml) (37.5%)/medetomidine (1 mg/ml) (25%)/sterile water
(37.5%) solution at 0.2 ml/100 g. Unilateral elevation of intraocular
pressure (IOP) was induced in the left eye only of 18 animals using an
adaptation of the Morrison method (Morrison et al., 1997) which has
been described, characterised and validated in our lab (Cordeiro et al.,
2004; Guo et al., 2005a,b, 2006, 2007). Brieﬂy, IOP was elevated by
injection of 50 μl of hypertonic saline solution (1.8 M) into the episcleral
veins, using a syringe pump (60 µl/min; UMP2, World Precision
Instruments, Sarasota, FL). Antibiotic ointment was then applied to
the eye. Animals were then allowed to recover from anaesthesia.
Baseline IOP measurements were made before IOP elevation, they
were then also measured after OHT induction at weekly intervals for a
month and monthly intervals thereafter using a rebound tonometer
(custom built at Department of Ophthalmology, Mount Sinai School of
Medicine, New York, NY) while animals were under isoﬂurane
anaesthesia (Merial; Animal Health, Ltd., Essex, UK). The differences
between IOP values of the unoperated and the IOP elevated eyes were
measured and statistical analysis was then performed using a one-
way ANOVA and Tukey honestly signiﬁcant difference (HSD) post hoc
analysis using SPSS.
For the superior colliculus in vitro slice preparation animals from
the OHT model group and the age matched control group were taken
at either 3, 16 or 32 weeks after IOP elevation or unoperated control at
the corresponding ages. Animals were anesthetised as above and leftfor 30 min. Animals were then decapitated and their brains were
removed rapidly and placed into ice-cold, oxygenated Krebs medium
containing (mM): sucrose 202, KCl 2, KH2PO4 1.25, MgSO4 10, CaCl2
0.5, NaHCO3 26, and glucose 10. The cerebellum and a small amount of
frontal cortex were removed and cuts were made on the right and left
hand sides parallel to the midline so that a ﬂat surface was revealed.
The ﬂat surface was then glued on one side to the cutting stage of a
vibratome (Integraslice 7550 MM, Campden Instruments, Lafayette,
Indiana, USA) with cyanoacrylate adhesive and parasagital slices of
400 μm thickness were cut through the superior colliculus. This
method allows the optic tract and its connections to the superﬁcial
layers of the superior colliculus to be maintained in slices from both
sides of the brain. Given that the retinal projection to the SC is more
than 90% crossed (Dreher et al., 1985), recordings were possible from
SC slices with RGC input from both the operated and unoperated eyes
from the same animal. After cutting, slices were transferred to a bath
containing oxygenated Krebs medium containing (mM): NaCl 124,
KCl 2, KH2PO4 1.25, MgSO4 5, CaCl2 1, NaHCO3 26, and glucose 10.
Slices were then left for at least 1 h before being transferred to an
interface recording chamber where they were perfused at a rate of
0.7 ml/min with warmed (33–34 °C) oxygenated Krebs medium
containing (mM): NaCl 124, KCl 2, KH2PO4 1.25, MgSO4 1, CaCl2 2,
NaHCO3 26, and glucose 10.
Stimulation to the optic tract immediately prior to its entry to the
SC was via a bipolar tungsten-in-glass electrode with extracellular
recordings being made in the superﬁcial grey layer of the SC via a
Krebs-ﬁlled glass micropipette (5–10 μm in diameter). Responses
were recorded using an Axoprobe 1A ampliﬁer (Axon Instruments),
digitised at 10 kHz via a CED1401 interface and stored on a computer
using Spike 2 software (Cambridge Electronic Design).
Each recording session was started by determining a minimum
and maximum response to stimulus intensity (0.1 ms pulses, 20 s
interval) for the slice and the intensity level was then set at 75% of that
which produced the maximum response. A stable baseline was then
recorded for 20 min. The GABA antagonists Picrotoxin (100 μM,
Sigma-Aldrich) and CGP55845 (3 μM, Tocris) were then added
together to the bathing medium for at least 20 min. This combination
of antagonists is known to block all three types of GABA receptor
(Bormann, 2000). The NMDA receptor antagonist D-AP5 (100 μM,
Ascent Scientiﬁc) was then added with the GABA antagonists to the
bathing medium for 10 min.
Responses to stimuli were waveform averaged (3 trials, equal to
60 s of recording) and the peak amplitude of the fEPSP was measured.
In addition, area under the curve measurements were made from the
peak of the fEPSP to 100 ms after stimulation to assess the effect of
GABA and NMDA antagonists on the late phase of the fEPSP (Fig. 1).
The fEPSP amplitude measurements taken for the last 3 min of drug
application were normalised and compared to baseline condition
measurements. In addition, the latency to peak of the fEPSP and the
duration of the fEPSP were measured at the same time points. The
effects of drugs on all these fEPSP parameters were statistically
analysed using paired t-tests and differences between the groups for
amplitude and receptor contribution measurements were analysed
using one-way ANOVA and a post hoc Tukey HSD test using SPSS
software.
Results
Measurements of IOP in the OHT model animals between 1 week
and 4 weeks after IOP elevation showed that there was a signiﬁcantly
greater IOP in the IOP elevated eyes compared to the unoperated eyes
(Fig. 2). This returned to baseline levels by 8 weeks after IOP elevation
in a manner similar to that seen previously in our laboratory (Guo
et al., 2006, 2007). In unoperated control animals there were no
signiﬁcant differences in the IOP of the left or right eyes at any of the
time points measured.
Fig. 1.Measurements for area under the curve for the late phase of the fEPSP and calculations for receptor contribution. The ﬁgure shows how the measurements of area under the
curve were taken and the calculations for both GABA receptor contribution and NMDA receptor contribution to the fEPSP. The area under the curve for each of the conditions was
measured from the peak of the fEPSP to 100 ms after this. The contribution of the GABA receptors to the fEPSP was measured using the calculation shown and is seen in grey shading
in the ﬁgure. Application of the NMDA receptor antagonist (D-AP5) reduced the amplitude and latency of the late phase of the excitatory fEPSP (revealed when GABA antagonists
were added) and the contribution of these receptors was measured using the calculation shown and is seen in the ﬁgure in grey hashing.
Fig. 2. IOP differences in left (IOP elevated) and right (unoperated) eyes in OHTmodel and agematched unoperated control (AMC) animals. The ﬁgure shows that there was a signiﬁcant
elevation of IOP in the operated eye compared to the unoperated eye for at least 4 weeks in OHT animals. In age matched controls there were no signiﬁcant differences in IOP values at
any of the time points measured. Values indicate IOP difference between operated and unoperated eyes with error bars indicating standard error of mean (** Pb0.01; * Pb0.05).
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evoked fEPSPs in the superﬁcial grey matter similar to those that we
have described previously in adult rats (Cirone et al., 2002; Pothecary et
al., 2005). Responses to stimulation under control conditions in
unoperated animals had a peak amplitude of around −0.7 mV and
latency to peak of 2 ms, and similar resultswere obtained irrespective of
from which side of the brain slices had been obtained (Tables 1 and 2).
GABA receptor contribution to synaptic responses
Application of the combination of GABA antagonists revealed an
increased amplitude and duration of the late phase of the fEPSP (Fig. 3)Table 1
The effect of GABA and NMDA receptor antagonists on peak amplitude of the fEPSP in age m
Baseline (normal Krebs) P
A - 3 weeks after IOP elevation
Age matched controls: Left (n=9) −0.71±0.08
Age matched controls: Right (n=8) −0.67±0.08 −
OHT: Left (input from unoperated eye) (n=10) −0.54±0.02 −
OHT: Right (input from operated eye) (n=10) −0.57±0.04 −
B - 16 weeks after IOP elevation
Age matched controls: Left (n=17) −0.7±0.05 −
Age matched controls: Right (n=14) −0.56±0.03
OHT: Left (input from unoperated eye) (n=10) −0.46±0.04 −
OHT: Right (input from operated eye) (n=10) −0.52±0.05 −
C - 32 weeks after IOP elevation
Age matched controls: Left (n=15) −0.54±0.03 −
Age matched controls: Right (n=13) −0.62±0.03 −
OHT: Left (input from unoperated eye) (n=12) −0.62±0.03 −
OHT: Right (input from operated eye) (n=14) −0.54±0.03 −as seen in previous studies from our laboratory (Mize and Salt, 2004;
Pothecary et al., 2005). In unoperated age-matched controls there was
no signiﬁcant difference in the contribution of GABA receptors to the
synaptic response in slices from the left superior colliculus compared to
slices from the right superior colliculus at 10 weeks old, 23 weeks old,
or 39 weeks old, corresponding to 3, 16, and 32 weeks after the OHT
elevation (Table 3). The duration of the late phase of the fEPSP while
GABA receptor antagonists were applied was not signiﬁcantly different
in slices from the left or right superior colliculus at any of the time
points (Table 4).
In animals where OHT glaucoma had been induced, the contribu-
tion of the GABA receptors to the synaptic response was also notatched controls and OHT model animals. Values are average (mV)±SEM of n values.
&C P-value Baseline (P&C) DAP5 P-value
−0.8±0.09 P=0.013 −0.79±0.08 −0.79±0.09 P=0.782
0.72±0.09 P=0.013 −0.7±0.08 −0.69±0.07 P=0.492
0.55±0.03 P=0.618 −0.55±0.03 −0.52±0.03 P=0.001
0.54±0.06 P=0.265 −0.54±0.06 −0.52±0.06 P=0.269
0.78±0.07 P=0.000 −0.77±0.07 −0.8±0.07 P=0.271
−0.6±0.05 P=0.119 −0.6±0.05 −0.61±0.06 P=0.095
0.47±0.05 P=0.655 −0.47±0.05 −0.45±0.05 P=0.042
0.54±0.08 P=0.700 −0.54±0.07 −0.55±0.08 P=0.597
0.57±0.04 P=0.106 −0.57±0.04 −0.55±0.04 P=0.372
0.69±0.04 P=0.002 −0.69±0.04 −0.69±0.04 P=0.829
0.72±0.05 P=0.003 −0.71±0.05 −0.73±0.06 P=0.171
0.56±0.03 P=0.123 −0.56±0.03 −0.55±0.04 P=0.028
Table 2
The effect of GABA and NMDA receptor antagonists on latency of the peak of the fEPSP in age matched controls and OHT model animals. Values are average (ms)±SEM of n values.
Baseline
(normal Krebs)
P&C P-value DAP5 P-value
A - 3 weeks after IOP elevation
Age matched controls: Left (n=9) 2±0.06 2±0.06 P=0.272 2±0.06 P=0.594
Age matched controls: Right (n=8) 1.8±0.07 1.8±0.08 P=0.785 1.9±0.07 P=0.685
OHT: Left (input from unoperated eye) (n=10) 2±0.06 2±0.06 P=0.081 2±0.05 P=0.168
OHT: Right (input from operated eye) (n=10) 1.8±0.07 1.8±0.05 P=0.193 1.8±0.05 P=0.678
B - 16 weeks after IOP elevation
Age matched controls: Left (n=17) 2.1±0.07 2.1±0.07 P=0.826 2.1±0.07 P=0.718
Age matched controls: Right (n=14) 1.9±0.08 1.9±0.08 P=1.000 1.9±0.07 P=0.336
Left (input from unoperated eye) (n=10) 2±0.09 2±0.09 P=0.443 2±0.09 P=0.591
Right (input from operated eye) (n=10) 1.8±0.07 1.8±0.07 P=0.853 1.8±0.07 P=0.279
C - 32 weeks after IOP elevation
Age matched controls: Left (n=15) 2±0.05 2.1±0.06 P=0.843 2.1±0.06 P=0.765
Age matched controls: Right (n=13) 1.8±0.03 1.7±0.04 P=0.165 1.7±0.03 P=0.673
Left (input from unoperated eye) (n=12) 1.9±0.07 1.9±0.06 P=0.845 1.9±0.09 P=0.909
Right (input from operated eye) (n=14) 1.8±0.06 1.8±0.07 P=0.212 1.8±0.08 P=0.752
Fig. 3. The effect of addition of GABA antagonists (Picrotoxin and CGP55845) and NMDA receptor antagonist (D-AP5) on the fEPSP in a slice taken from an age matched unoperated
control animal aged 22 weeks. A - fEPSP recorded under control conditions in normal Krebs solution. B - When GABA antagonists to all 3 types of GABA receptor were applied this
revealed an enhanced excitatory component of the fEPSP. C - When the NMDA receptor antagonist D-AP5 (100 μM) was added in addition to the GABA antagonists this caused a
reduction in the late phase of the fEPSP, indicating the contribution of the NMDA receptors to this excitatory component of the response. D - Overlay of traces A,B & C.
Table 3
Contribution of the GABA receptors to the fEPSP and contribution of the NMDA
receptors to the excitatory fEPSP in age matched unoperated controls and OHT model
animals. Values are average (%)±SEM of n values.
Contribution of
GABA receptors
to the fEPSP (%)
Contribution of
NMDA receptors
to the excitatory
fEPSP (%)
A - 3 weeks after IOP elevation
Age matched controls: Left (n=9) 85.4±1.4 62.7±2.5
Age matched controls: Right (n=8) 82±1.2 65.5±1.6
P value left vs. right P=0.191 P=0.887
OHT: Left (input from unoperated eye)
(n=10)
86±1.2 62±2.7
OHT: Right (input from operated eye)
(n=10)
84±0.7 64±3.2
P value OHT left vs. right P=0.634 P=0.947
B - 16 weeks after IOP elevation
Age matched controls: Left (n=17) 82.6±1.7 53.4±2.1
Age matched controls: Right (n=14) 81.5±2.9 55.5±2.1
P value left vs. right P=0.981 P=0.885
OHT: Left (input from unoperated eye)
(n=10)
85±2.4 60±2.4
OHT: Right (input from operated eye)
(n=10)
85±1.1 62±2.2
P value OHT left vs. right P=1.000 P=0.971
C - 32 weeks after IOP elevation
Age matched controls: Left (n=15) 84.4±1.1 57±1.7
Age matched controls: Right (n=13) 85.8±1.3 62.9±2.6
P value left vs. right P=0.933 P=0.364
OHT: Left (input from unoperated eye)
(n=12)
83±1.5 53±2.9
OHT: Right (input from operated eye)
(n=14)
80±2.4 67±3
P value OHT left vs. right P=0.661 P=0.001
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the unoperated eyes compared with those with input from the
glaucomatous eyes at 3, 16 or 32 weeks after IOP elevation (Table 3,
Fig. 4 A). The duration of the late phase of the fEPSP while GABA
receptor antagonists were applied was not signiﬁcantly different in
superior colliculus slices with input from the unoperated eyes or
glaucomatous eyes at any of the time points (Table 5).
In both age matched control animals and OHT animals, at all time
points, the addition of GABA antagonists caused an increase in
the peak amplitude of the fEPSP although this was not always
signiﬁcant (Table 1). There were no signiﬁcant changes in the latency
of the peak of the fEPSP due to addition of GABA receptor antagonists
in age matched controls or OHT animals at any of the time points
(Table 2).
NMDA receptor contribution to fEPSPs
Removal of GABAergic inhibition by application of GABA antago-
nists revealed a fEPSP that is a composite of non-NMDA receptor and
NMDA receptor-mediated components (Cirone et al., 2002; Pothecary
et al., 2005). Under these conditions it was possible to investigate the
relative contribution of NMDA receptors and non-NMDA receptors to
fEPSPs by applying an NMDA antagonist in addition to the GABA
antagonist combination. Thus, application of the NMDA receptor
antagonist D-AP5 reduced the amplitude and duration of the late
phase of the fEPSP (Fig. 3) as has been previously shown in our
laboratory (Pothecary et al., 2005). In unoperated age matched
control animals there was no signiﬁcant difference in the contribution
of the NMDA receptors to the excitatory fEPSP between the left and
right superior colliculus slices in any of the age groups (Table 3).
Table 4
The effect of GABA and NMDA receptor antagonists on the duration of the fEPSP in age matched unoperated controls. Values are average (ms)±SEM of n values.
Baseline (normal Krebs) P&C P-value DAP5 P-value
A - 10 weeks old (Equivalent 3 weeks after IOP elevation)
Left (n=9) 4.1±0.19 96±7.9 P=0.000 33±3.4 P=0.000
Right (n=8) 3.7±0.11 90±3.1 P=0.000 26±1.9 P=0.000
B - 23 weeks old (Equivalent 16 weeks after IOP elevation)
Left (n=17) 4.3±0.17 85±6.0 P=0.000 34±2.5 P=0.000
Right (n=14) 4.1±0.13 84±6.3 P=0.000 30±2.3 P=0.000
C - 39 weeks old (Equivalent 32 weeks after IOP elevation)
Left (n=15) 4.2±0.24 75±6.7 P=0.000 26±2.2 P=0.000
Right (n=13) 3.7±0.17 72±5.0 P=0.000 21±2.1 P=0.000
There were no signiﬁcant differences between the Left and Right slices during each condition (baseline, P&C, or DAP5) at each time point (PN0.05).
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while D-AP5 was applied was not signiﬁcantly different in left or right
superior colliculus slices at any of the time points (Table 4), indicating
that there were no differences in the non-NMDA receptor mediated
component of the fEPSP in these animal groups.
The contribution of the NMDA receptors to the fEPSP was not
signiﬁcantly different in superior colliculus slices receiving input
from the unoperated eyes compared to those with input from the
glaucomatous eyes at 3 weeks or 16 weeks after IOP elevation
(Table 3). However at 32 weeks after IOP elevation there was a
signiﬁcant increase in the NMDA receptor contribution to the
excitatory fEPSP in slices receiving input from the glaucomatous
eyes (67±3%) compared to slices receiving input from the unoper-Fig. 4. GABA receptor (A) and NMDA receptor (B) contribution to the fEPSP in OHT model an
the fEPSP between slices with input from the glaucomatous eyes compared to those with inp
matched control (AMC) data from slices from both hemispheres of the superior colliculus ar
NMDA receptor contribution to the excitatory fEPSP between slices with input from the glauc
after IOP elevation. However at 32 weeks after IOP elevation there was a signiﬁcantly greate
glaucomatous eyes compared to those with input from unoperated eyes.ated eyes (53±2.9%, P=0.001, Fig. 4 B) and to slices from the age
matched unoperated control animals (60±1.6%, P=0.046). Slices
with input from the unoperated eyes in the OHT model animals did
not show any signiﬁcant difference in NMDA receptor contribution to
the fEPSP compared to the age matched unoperated control slices
(P=0.083). Examples of the traces seen for the fEPSPs in slices with
input from the IOP elevated (operated) eyes compared to those with
input from the unoperated eyes at 32 weeks after IOP elevation in
OHT model animals can be seen in Fig. 5.
The duration of the late phase of the fEPSP while D-AP5 was
applied was not signiﬁcantly different in superior colliculus slices
with input from the unoperated eyes or glaucomatous eyes at any of
the time points after OHT induction (Table 5), indicating that thereimals. A -There were no signiﬁcant differences in the contribution of GABA receptors to
ut from the unoperated eyes in OHT model animals at any of the time points tested. Age
e shown for comparison in both graphs. B -There were no signiﬁcant differences in the
omatous eyes compared to those with input from the unoperated eyes at 3 or 16 weeks
r contribution of NMDA receptors to the excitatory fEPSP in slices with input from the
Table 5
The effect of GABA and NMDA receptor antagonists on the duration of the fEPSP in OHT model animals. Values are average (ms)±SEM of n values.
Baseline
(normal Krebs)
P&C P-value DAP5 P-value
A- 3 weeks after IOP elevation
Left (input from unoperated eye) (n=10) 4.3±0.16 77±3.7 P=0.000 23±1.6 P=0.000
Right (input from operated eye) (n=10) 4.1±0.15 81±4.1 P=0.000 25±2.2 P=0.000
B - 16 weeks after IOP elevation
Left (input from unoperated eye) (n=10) 4.2±0.22 73±4.3 P=0.000 23±2.8 P=0.000
Right (input from operated eye) (n=10) 3.9±0.13 79±6.6 P=0.000 26±2.9 P=0.000
C - 32 weeks after IOP elevation
Left (input from unoperated eye) (n=12) 4.2±0.17 66±5.5 P=0.000 24±2 P=0.000
Right (input from operated eye) (n=12) 3.9±0.12 60±3.1 P=0.000 19±0.96 P=0.000
There were no signiﬁcant differences between the Left and Right slices during each condition (baseline, P&C, or DAP5) at each time point (PN0.05).
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these groups of animals.
Application of the NMDA antagonist D-AP5 caused no signiﬁcant
change in the peak amplitude of the fEPSP in age matched control
animals and in the OHT animals it either caused a small decrease or no
signiﬁcant change (Table 1). There was no signiﬁcant effect of D-AP5
application on the latency of the peak of the fEPSP in age matched
unoperated controls or OHT model animals (Table 2).
Discussion
In the present study we have found that the NMDA receptor
contribution to the optic tract-evoked fEPSP was signiﬁcantly
increased in superior colliculus slices with input from the glaucoma-
tous eyes compared to those with input from the unoperated eyes.
Interestingly, these changes were seen at 32 weeks after induction of
OHT glaucoma rather than at the earlier time points after IOP
elevation. Thus the NMDA receptor contribution to synaptic trans-Fig. 5. Examples of the effect of addition of GABA antagonists (Picrotoxin and CGP55845) and
eye and those with input from the unoperated eye at 32 weeks after IOP elevation (left-hand
the difference between the GABA antagonist traces and D-AP5 traces on the right-hand side o
contribution of NMDA receptors to the fEPSP. In this slice there was an 85% contribution of t
fEPSP (see Fig. 1 for details of calculation). B - An example from a slice with input from the op
AP5) on the fEPSP. In this slice there was an 80% contribution of the GABA receptors to themission in the superior colliculus is changed in this rat OHT model of
glaucoma only at the later stage of the disease and this may be due to
changes in the expression and/or function of these receptors. A
previous study in an enucleation model of RGC degeneration showed
no change in the expression of NMDA receptors in the superior
colliculus up to 20 days after surgery (Chalmers and McCulloch,
1991b). However, and perhaps more relevant, a study in a primate
model of glaucoma has shown that the NR1 subunit of the NMDA
receptor is increased in the LGN layers connected to the glaucomatous
eye 8-11 months after IOP elevation but not earlier (Yucel et al.,
2006). This data by Yucel et al. (2006) showing an increase in the NR1
subunit suggests the speculation that a similar change is occurring in
the superior colliculus in our rat model of glaucoma, indicating that
the changes in NMDA receptor contribution seen in the present study
may be due to increased NMDA receptor expression. However, this
does not exclude other possibilities such as dendritic changes that
may result in differences in synaptic transmission (Gupta et al., 2007;
Liu et al., 2008).NMDA receptor antagonist (D-AP5) on the fEPSP in slices with input from the operated
side overlaid traces). The contribution of NMDA receptors to these fEPSPs is shown as
f each row. A - An example from a slice with input from the unoperated eye showing the
he GABA receptors to the response and 54% contribution of the NMDA receptors to the
erated (IOP elevated) eye, showing a greater effect of the NMDA receptor antagonist (D-
response and 68% contribution of the NMDA receptors to the fEPSP.
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glaucoma model, the apoptosis rate of RGCs peaks at ∼3 weeks after
OHT induction, but that there is a continuing increasing loss of RGCs,
so that by 16 weeks after IOP elevation the loss of RGCs exceeds 50%
(Cordeiro et al., 2004). This indicates that few central changes occur
during the early stages of the degeneration when apoptosis is
maximal but when the total RGC loss is still relatively little. Our
ﬁnding that it is only later than 16 weeks that there is a signiﬁcant
change in NMDA receptor contribution to SC responses suggests that
it is not apoptosis as such, but a substantial and relatively prolonged
RGC degeneration that is required to provoke central changes. This
would be consistent with the NMDA receptor expression studies in
primate glaucoma models, showing elevated NR1 expression at later
stages of the disease (Yucel et al., 2006). Our ﬁndings thus suggest
that if the progression of the disease could be halted at an early stage
(e.g. by reduction in peak apoptosis) then central changes may be
prevented. This indicates that early therapeutic intervention in
glaucoma is not only desirable for retaining retinal function, but
also for retaining normal function in retino-recipient brain areas.
Our ﬁnding in that a large contribution of NMDA receptors to the
optic-tract evoked fEPSP is revealed when GABAergic inhibition is
blocked is consistent with our previous ﬁndings (Pothecary et al.,
2005). Similarly, Pothecary et al. (2005) found that in the later stages
of retinal degeneration in the Royal College of Surgeons (RCS)
dystrophic rat, there is an increased NMDA receptor contribution to
SC synaptic responses. This suggests that there may be common
central consequences of retinal degeneration or RGC degeneration in
different disease syndromes and that this includes changes in NMDA
receptor contribution to synaptic transmission. Furthermore, given
the importance of NMDA receptors in synaptic plasticity and learning,
both during development and in adulthood (Malenka and Nicoll,
1993; Collingridge and Bliss, 1995; Constantine-Paton, 2000; Rao and
Finkbeiner, 2007; Citri and Malenka, 2008; Cohen and Greenberg,
2008), an increase in NMDA receptor function in the retinal disease
syndromes suggests that there may also be scope for increased
synaptic plasticity in these conditions. This suggests that there is
possibility for plasticity within the superior colliculus after RGC
degeneration and the loss of retinal input to the area which may hold
promise for recovering visual function.
The present study has also conﬁrmed the large inhibitory inﬂuence
of GABA receptors on synaptic transmission in the superior colliculus
as seen in previous studies by our lab (Cirone et al., 2002; Pothecary
et al., 2002; Mize and Salt, 2004; Lacey et al., 2005; Pothecary et al.,
2005). Previous studies have shown that up to 20 days after eye
enucleation there is no change in the GABAA receptor expression in
the contralateral superior colliculus (Segu et al., 1986; Chalmers and
McCulloch, 1991a). The data from the present study showing no
change in the GABA receptor contribution to the SC synaptic response
in the glaucoma model appears to agree with this data. How-
ever, although the overall contribution of all 3 receptor types appears
to be unchanged this does not mean that there are no changes in
the GABA receptors at all, and it may be that there are more subtle
speciﬁc changes in progress. For example, other studies in eye
enucleation models have suggested that the GABA-ergic neurons and
terminals within the contralateral superior colliculus may show
some rearrangement 6 weeks after surgery (Lund and Lund, 1971;
Houser et al., 1983), and Turner et al. (2005) found changes in SC
inhibitory circuitry following optic nerve transection. Therefore it
would be interesting in future studies to look at the expression of
individual GABA receptor types in the superior colliculus in rat
glaucoma.
The data from both the present and the previous studies discussed
suggest the importance for further studies into the changes that occur
in the central areas consequent to RGC degeneration. These changes
will need to be considered when designing treatments for retinal
degenerative diseases including glaucoma.Conclusions
The data from this study show that there are functional changes
that occur in the central visual targets for RGCs in rodent glaucoma
models. In particular, we have seen that there is an increase in the
contribution of NMDA receptors to synaptic transmission in the
superior colliculus in the rodent OHT glaucoma model, and that these
changes occur at a relatively late stage after the main phase of
apoptotic RGC loss. The data suggest ﬁrstly, that early therapeutic
intervention in glaucoma may be important to prevent CNS changes,
and secondly that there may be a potential ability for central areas to
show plasticity following the loss of retinal input, and this may aid in
the design of future treatment for limiting visual loss in glaucoma.
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